Customized Protein Nanoreactors for Affibody-Directed Activation of 5-Fluorcytosin in HER2-Positive Cells
Mariia Zmyslia, Martin Holzer, Claudia Jessen‐Trefzer
This paper develops encapsulin nanoreactors that target HER2-positive cells and convert 5-fluorocytosine into 5-fluorouracil, reducing cell viability by 83%.
bioRxiv · Sep 11, 2025 · PreprintCancer Biology